Treatment of Patients with Advanced Thyroid Cancer

Publisher： Bentham Science Publishers

E-ISSN： 2468-4236|6|1|10-25

ISSN： 2468-4228

Source： Current Biomarkers, Vol.6, Iss.1, 2017-01, pp. : 10-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Background: Thyroid cancers are frequent in the endocrine system especially differentiatedthyroid carcinoma and 95% of all thyroid cancer cases are differentiated neoplasmas. They have a favorableprognosis; however although, a small group present recurrence in 10-15% of patients followingthe standard treatment, surgery and radioiodine. Medullary thyroid carcinoma which is a neoplasmof the parafollicular C cells of the thyroid is responsible for a high number of thyroid cancer related deaths.lt;pgt

Related content

Personalization of Targeted Therapy in Advanced Thyroid Cancer

By  

Current Genomics, Vol. 15, Iss. 3, 2014-01 ,pp. : 190-202 (13)

Bentham Science Publishers

Access to resources Recommend Favorite

A cytogenetic follow-up study of thyroid cancer patients treated with 131 I

By Gutierrez S.   Carbonell E.   Galofre P.   Xamena N.   Creus A.   Marcos R.  

Mutation Research/Environmental Mutagenesis and Related Subjects, Vol. 360, Iss. 3, 1996-08 ,pp. : 235-236 (2)

Elsevier

Access to resources Recommend Favorite

Editorial (Thematic Issue: “Molecular Profiling and Ways Towards Personalized Medicine in Advanced Differentiated Thyroid Cancer”)

By  

Current Genomics, Vol. 15, Iss. 3, 2014-06 ,pp. : 161-161 (1)

Bentham Science Publishers

Access to resources Recommend Favorite

Telomeres and Thyroid Cancer

By  

Current Genomics, Vol. 10, Iss. 8, 2009-12 ,pp. : 526-533 (8)

Bentham Science Publishers

Access to resources Recommend Favorite

New Targeted Therapies for Thyroid Cancer

By  

Current Genomics, Vol. 12, Iss. 8, 2011-12 ,pp. : 626-631 (6)

Bentham Science Publishers

Access to resources Recommend Favorite